Objective A systematic review and meta-analysis to compare the diagnostic performance of
prostate-specific membrane antigen (PSMA)-PET/CT, choline-PET/CT, Sodium Fluoride …

Prostate-specific membrane antigen PET/CT for primary staging of prostate cancer is
becoming increasingly popular due to simultaneous assessment of whole-body disease …

Oligometastatic disease represents a clinical and anatomical manifestation between
localised and polymetastatic disease. In prostate cancer, as with other cancers, recognition …

Background PSMA PET is a promising method for primary lymph node staging in prostate
cancer. However, recent systematic reviews have identified only a limited number of studies …

Imaging of the prostate-specific membrane antigen (PSMA) has become an important tool
for managing patients with recurrent prostate cancer, and one of the most frequently …

Prostate-specific membrane antigen (PSMA)–targeted radiopharmaceuticals are playing a
large role at the time of initial staging and biochemical recurrence for localizing prostate …

Prostate cancer is the second most common cause of malignancy among men, with bone
metastasis being a significant source of morbidity and mortality in advanced cases …

Observer-driven pattern recognition is the standard for interpretation of medical images. To
achieve global parity in interpretation, semi-quantitative scoring systems have been …

More than 40% of men with intermediate-risk or high-risk prostate cancer will experience a
biochemical recurrence after radical prostatectomy. Clinical guidelines for the management …

Background: Initial staging and assessment of treatment activity in metastatic prostate
cancer (PCa) patients is controversial. Indications for the various available imaging …